TEVA: Se anota a la puerta giratoria...

BY ALICIA MUNDY

The longtime head of the generic drug division at the U.S. Food and Drug Administration is going to work for the world's largest generic-drug maker, Teva Pharmaceutical Industries Ltd.

Gary Buehler will become vice president for regulatory strategic operations at Teva, the company said.

In March, Mr. Buehler was nudged out of his leadership post at the FDA's generic office into another role at the agency.

Ver tambien

De Juan Gérvas: Pandemia de Gripe A (2009 - 2010) Incoherencias y falta de transparencia